From kaisernetwork.org Daily Reports. Feb. 8,2000 ADMINISTRATION WATCH "Bush Working To Balance Pressures from Drug Industry, Advocates in Selecting FDA Head The New York Times examines the "political quandary" President Bush faces as he attempts to appoint an FDA commissioner, a position that has remained empty for more than a year (Stolberg, New York Times, 2/8). The last FDA commissioner, Jane Henney, resigned in January 2001 (Kaiser Daily Health Policy Report, 12/21/01). According to the Times, legislators and drug industry executives have criticized Bush for "not plac[ing] a high enough priority on filling" the position. Sen. Ron Wyden (D-Ore.) said, "It is critically important that the president get names up on the Hill so that we can begin the confirmation process. I'm hearing an unprecedented coalition of public interest groups, entrepreneurs and scientists saying that, at a critical time when we are about to spend billions of dollars fighting bioterrorism, there just isn't anybody home at these key agencies." However, the Times reports that Bush faces a "dilemma." If he names a candidate from the drug industry, he may face the "wrath" of Senate Democrats. However, a nominee from outside the drug industry could upset pharmaceutical companies, who gave Bush "considerable campaign support" in the last election. According to the Times, the conflict has already "scuttled" one possible candidate. In July, the administration put forward the name of Michael Astrue, general counsel for the Cambridge, Mass.-based biotech company Transkaryotic Therapies, as a possible commissioner. Seven Democratic senators, including Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.), objected (New York Times, 2/8). Kennedy said he would not hold confirmation hearings if Astrue were nominated, surprising White House officials who expected the Massachusetts lawmaker to "welcome" an FDA nominee from his home state (Kaiser Daily Health Policy Report, 10/31/01). "It would be unprecedented for anyone to be appointed from an industry regulated by the FDA, and now is not the time to start," Kennedy spokesperson James Manley said. Concerns Over Wood Currently, Vanderbilt University drug safety expert Dr. Alistair Wood is a "leading candidate," according to the Times. However, the Times reports that the conflict of interests "is playing out again," as executives from the drug industry "are not keen" on Wood. According to the Times, drug executives see Wood as a potentially "overly aggressive regulator" after a "string" of drug recalls and patient deaths led him to call for the FDA to be "more aggressive" in drug monitoring. According to the Times, HHS Secretary Tommy Thompson on Feb. 4 sent Bush a list of three candidates each for the FDA position and the unfilled NIH director position. The Times reports that Bush is seeking a candidate who "understands the drug approval process" and could "streamline the agency's bureaucracy." Dr. David Kessler, a former FDA commissioner in the previous Bush administration, said, "The president is getting squeezed from all sides. The job of the agency is to protect public health, and it needs leadership" (New York Times, 2/8). Carmona Recommended for Surgeon General Meanwhile, the Arizona Daily Star reports that Dr. Richard Carmona, a trauma surgeon in Tucson, Ariz., has been recommended as a candidate to replace Surgeon General David Satcher, whose term ends this month. According to the Star, U.S. Rep. Jim Kolbe (R-Ariz.) and Dr. Edmund Krasinski, president of the Pima County Medical Society, have written letters to President Bush recommending Carmona for the position. In addition, Carmona said he has been contacted by the White House regarding the position. A White House spokesperson refused to comment, the Star reports. Carmona currently works as the chair and medical director of the Southern Arizona Emergency Medical System Council and is a professor of surgery, public health and family and community medicine for the University of Arizona. "He is a rugged gem from the streets of New York who found his way to the Arizona desert. He will shine in Washington," Krasinski wrote in his letter (Salkowski, Arizona Daily Star, 2/8)." --------------------------- Please come and visit our site for future daily reports, or sign up for our Email-Alert mailing list to automatically receive future reports at http://www.kaisernetwork.org/email Health Policy As It Happens http://www.kaisernetwork.org ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn